BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1566496)

  • 1. Prolongation of hamster to rat xenograft survival by rapamycin.
    Chen H; Xu D; Wu J; Daloze P
    Transplant Proc; 1992 Apr; 24(2):715-6. PubMed ID: 1566496
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular transplantation of Syrian hamster heart into Lewis rat: effect of brequinar, cyclosporine, cobra venom factor, and splenectomy.
    Schuurman HJ; Joergensen J; Kuipers H; Meerloo T; Lardelli P; Hiestand P; White DH; Schreier MH
    Transplant Proc; 1994 Jun; 26(3):1217-9. PubMed ID: 8029893
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival of hamster heart xenografts in rat recipients on a relatively mild immunosuppressive protocol.
    Scheringa M; Töns A; Bouwman E
    Transplant Proc; 1996 Apr; 28(2):833-4. PubMed ID: 8623423
    [No Abstract]   [Full Text] [Related]  

  • 4. Xenograft adaptation is dependent on the presence of antispecies antibody, not prolonged residence in the recipient.
    Hasan R; Van den Bogaerde J; Forty J; Wright L; Wallwork J; White DJ
    Transplant Proc; 1992 Apr; 24(2):531-2. PubMed ID: 1566418
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival.
    Wang J; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):699-702. PubMed ID: 1990655
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged survival of guinea pig-to-rat heart xenografts using repeated low doses of cobra venom factor.
    Tavakoli R; Michel A; Cardoso J; Ayani E; Maillet F; Fontaliran F; Crougneau S; Weill B; Houssin D
    Transplant Proc; 1993 Feb; 25(1 Pt 1):407-9. PubMed ID: 8438356
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival.
    Stepkowski SM; Wang M; Qu X; Yu J; Okamoto M; Tejpal N; Kahan BD
    Transplant Proc; 1998 Aug; 30(5):2214-6. PubMed ID: 9723445
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
    [No Abstract]   [Full Text] [Related]  

  • 9. Hamster to rat xenografts are not rejected primarily by rat T cells.
    van den Bogaerde JB; Aspinall R; White DJ
    Transplant Proc; 1991 Aug; 23(4):2277-9. PubMed ID: 1871870
    [No Abstract]   [Full Text] [Related]  

  • 10. Rescue therapy with rapamycin blocks an ongoing process of heart allograft rejection.
    Ferraresso M; Wang ME; Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):729. PubMed ID: 8438460
    [No Abstract]   [Full Text] [Related]  

  • 11. An analysis of concordant xenografting.
    van den Bogaerde J; Hassan R; White DG
    Transplant Proc; 1992 Apr; 24(2):513-4. PubMed ID: 1566410
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
    Hamashima T; Stepkowski SM; Smith S; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor.
    Kobayashi T; Taniguchi S; Ye Y; Niekrasz M; Kosanke S; Neethling FA; Wright LJ; Rose AG; White DJ; Cooper DK
    Transplant Proc; 1996 Apr; 28(2):560. PubMed ID: 8623270
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
    Chen H; Wu J; Luo H; Daloze P
    Transplant Proc; 1992 Jun; 24(3):892-3. PubMed ID: 1604658
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of antibody synthesis and complement activation in concordant xenograft retransplantation.
    Gannedahl G; Karlsson-Parra A; Wallgren A; Roos-Engstrand E; Nilsson B; Tötterman TH; Tufveson G
    Transplantation; 1994 Aug; 58(3):337-44. PubMed ID: 8053058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of rapamycin, RS-61443, and cyclophosphamide in the prolongation of survival of discordant pig-to-rabbit cardiac xenografts.
    Yatscoff RW; Wang S; Keenan R; Chackowsky P; Koshal A
    Transplant Proc; 1994 Jun; 26(3):1271-3. PubMed ID: 8029905
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of cyclosporine alone or in combination with rapamycin and brequinar on survival of hamster heart xenograft in rats.
    Wang M; Tu Y; Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Oct; 25(5):2876-7. PubMed ID: 8212271
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
    Xiao F; Chong A; Foster P; Sankary H; McChesney L; Williams JM; Frieders D; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.